31
IPC Use in Lymphedema: Physiological Considerations Harvey N. Mayrovitz PhD, Professor of Physiology College of Medical Sciences, Nova Southeastern University Ft. Lauderdale Florida [email protected] ICC meeting Boston 9/8/2013

IPC Use in Lymphedema: Physiological Considerations

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: IPC Use in Lymphedema: Physiological Considerations

IPC Use in Lymphedema: Physiological Considerations

Harvey N. Mayrovitz PhD, Professor of PhysiologyCollege of Medical Sciences, Nova Southeastern University

Ft. Lauderdale Florida [email protected] meeting Boston 9/8/2013

Page 2: IPC Use in Lymphedema: Physiological Considerations

Brief Excursion into Normal Physiological Process Consideration

Page 3: IPC Use in Lymphedema: Physiological Considerations

LymphaticCapillaryLumen

junction

Leak 1971

Capillary  Tissue  Lymph Capillary

PL

PT

PL Leak 1971

Lymphatic EC

Interstitium

Page 4: IPC Use in Lymphedema: Physiological Considerations

Capillary  Tissue  Lymph Capillary

EC

Lumen PL

PT

EC

Lumen PL

PT

PL

> PT

PL

< PT

AnchoringFilaments Blood Capillary

“Blind”

Lymphatic Capillary

Fluid and Protein enterLymphatic Capillaries

LymphaticCapillaryLumen

junction

Leak 1971

Page 5: IPC Use in Lymphedema: Physiological Considerations

ValveLymphangion(lymph micro heart)

LymphCapillary

Walls have amuscular

media

Lymph taken up by lymphatic capillaries enters lymph collectors

Collection  Propulsion

valve

Grimaldi et al. 2006

Page 6: IPC Use in Lymphedema: Physiological Considerations

ValveLymphangion(lymph micro heart)

LymphCapillary

Walls have amuscular

media

Contraction force & frequency is preload & afterload dependent ‐

analogous to heart

Peristaltic‐like contractionspropel lymph to next segment

Collection  Propulsion

valve

Grimaldi et al. 2006

Page 7: IPC Use in Lymphedema: Physiological Considerations

Excess ‐‐> Lymphatics

Fluid +Protein

capillary

Normal Lymphatic Function

Page 8: IPC Use in Lymphedema: Physiological Considerations

Overload = Edema+ [Protein]

= Lymphedema= Lymphedema

If Net Filtration ExceedsLymphatic Transport Capacity

Excess ‐‐> Lymphatics

Fluid +Protein

capillary

Normal Lymphatic Function

Page 9: IPC Use in Lymphedema: Physiological Considerations

LN

VerticalWatershed

NORMAL

TransverseWatershed

Veins LN

VerticalWatershed

LYMPHEDEMA

TransverseWatershed

Veins

Lymphatic Drainage Pathways

Lymph flow and drainage determined by normal physiological processes and lymphatic pathways

Lymph flow through normal pathways

reduced or absent

due to node or lymph vessel obstruction or dysfunction

Page 10: IPC Use in Lymphedema: Physiological Considerations

PL

PLV

QL

LymphaticPressure

LymphaticFlow

LNVeins

Lymph

QL~PL - PLV

R

NORMAL

Therapeutic StrategyUse Alternate Pathways –

Stimulate Lymphatics and 

Optimize Conditions for IPC related pumping

Lymph flow depends on pathway pressure gradient and resistance

PL

PLV

QL

LYMPHEDEMA

LN LN

Treatment RelatedLymphFlow

PT1

PT2

StimulatedLymphatics

Treatment RelatedLymph Flow in 

IPC‐RelatedAugmentation

Page 11: IPC Use in Lymphedema: Physiological Considerations

Adjunctive IPC Lymphedema Therapy

Basic: Few Adjustments – Not ProgrammableAdvanced:

Calibrated‐Sequential‐Programmable 

ROLEPhase I  Component of in‐clinic therapy

Phase II  At‐home maintenance therapy

• With Truncal Clearance Capability• No Truncal Clearance Capability

TYPES

Page 12: IPC Use in Lymphedema: Physiological Considerations

Not independent considerations

IPC Compression• Pattern• Progression• Pressure

Physiological Considerations

Page 13: IPC Use in Lymphedema: Physiological Considerations

010203040506070

0 10 20 30 40 50

G1G2G3G4G5

Flexitouch®

System

Compression Pattern Examples

010203040506070

0 10 20 30 40 50

G1G2G3G4G5

Lympha Press®

System

Drainage

“Work & Release”

Mayrovitz HNPhysical Therapy 2007;87:1379‐1388

“Squeeze & Hold”

Peristaltic‐likeProgression

seconds

Skin In

terface Pressure (m

mHg)

Page 14: IPC Use in Lymphedema: Physiological Considerations

Proximal/Central clearance prior to

forward propulsion 

Distal  Central progressive propulsion     

Physiological Considerations

Page 15: IPC Use in Lymphedema: Physiological Considerations

LN Veins

3

4

5

Clearnormal adjacenttrunk areas

LN

122Clear affected trunk areas

LNInguinalNodes

Prepareabdominal region

A. First sequentially treat lymph receiving regions (15) to optimize gradient and minimize resistance for 

subsequent limb drainage procedures

Advanced IPC Progression Approach

Mayrovitz et al. Home Health Care Management & Practice 2009;21(5) 325‐337Hammond & Mayrovitz Home Health Care Management & Practice 2010;22(6) 397‐402

Page 16: IPC Use in Lymphedema: Physiological Considerations

LN Veins

3

4

5

Clearnormal adjacenttrunk areas

LN

122Clear affected trunk areas

LNInguinalNodes

Prepareabdominal region

B. Then progressive treatment of limb and trunk with suitable pump pressure starting at the most peripheral region ( 5  1)

Advanced IPC Progression Approach

Page 17: IPC Use in Lymphedema: Physiological Considerations

Proximal/Central clearance prior to

forward propulsion 

Distal  Central progressive propulsionwith minimal inhibition

of: 

• Distal lymphatic capillary interstitial fluid uptake

• Lympho‐venous flow

Physiological Considerations

Page 18: IPC Use in Lymphedema: Physiological Considerations

Pattern Considerations

Page 19: IPC Use in Lymphedema: Physiological Considerations

ArterioleBlood

Capillary

LymphoVenousShunt

Venulereabsorption

LymphaticCapillaryUptake

Filtration

P0

P = P0

P0

Ppump

max~40 mmHg

P = P0

0.6‐0.8

~

3s~ 30s

Arm: Modi

et al. 2007Leg: Unno

et al. 2011

*

* Olszewski

& Engesgt

1980 

Page 20: IPC Use in Lymphedema: Physiological Considerations

Pressure Considerations

Page 21: IPC Use in Lymphedema: Physiological Considerations

Lower Pressure vs. Higher Pressure

• Facilitate lymph movement in functioning lymphatics• Minimize inhibition of lymph  filling during compression• Minimize potential injury  due to higher pressures• Provide a comfortable  treatment experience for patients

Lower Pressures

Higher Pressures• Facilitate directional interstitial fluid movement especially if low interstitial hydraulic conductance  

Page 22: IPC Use in Lymphedema: Physiological Considerations

IPC use in lymphedema should be consistent with Physiological considerations of• Initial Central Clearance • Subsequent Progressive Propulsion

Summary View

Page 23: IPC Use in Lymphedema: Physiological Considerations

Summary ViewIPC use in lymphedema should be consistent with Physiological considerations of• Initial Central Clearance • Subsequent Progressive PropulsionUsing Compression Pressures and Patterns thatduring compression minimally inhibit • lymph capillary uptake• lymphatic intrinsic active pumping• lymph –

venous uptake and drainage

Page 24: IPC Use in Lymphedema: Physiological Considerations

Summary ViewIPC use in lymphedema should be consistent with Physiological considerations of• Initial Central Clearance • Subsequent Progressive PropulsionUsing Compression Pressures and Patterns thatduring compression minimally inhibit • lymph capillary uptake• lymphatic intrinsic active pumping• lymph –

venous uptake and drainage

And facilitate lymph vessel and tissue lymph flow via • Impulse –

like progressive compression

• arterial‐lymphatic interactions that tend tooccur at lower compression pressures

Page 25: IPC Use in Lymphedema: Physiological Considerations

Examples of Some Research Study 

Outcomes

Page 26: IPC Use in Lymphedema: Physiological Considerations

Author Outcomes

Muluk, et al (2013)European J of VascEndovasc Surg

Legs:  Significant Limb volume; significantly improved patient‐reported outcomes

Author Outcomes

Muluk, et al (2013)European J of VascEndovasc Surg

Legs:  Significant Limb volume; significantly improved patient‐reported outcomes

Research Study Outcomes

Page 27: IPC Use in Lymphedema: Physiological Considerations

Author Outcomes

Muluk, et al (2013)European J of VascEndovasc Surg

Legs:  Significant Limb volume; significantly improved patient‐reported outcomes

Fife, et al (2012)Supportive Care in Cancer

BCRL: 29%Limb volume vs 16% limb volume with standard pump use

Author Outcomes

Muluk, et al (2013)European J of VascEndovasc Surg

Legs:  Significant Limb volume; significantly improved patient‐reported outcomes

Fife, et al (2012)Supportive Care in Cancer

BCRL: 29%Limb volume vs 16% limb volume with standard pump use

Research Study Outcomes

Page 28: IPC Use in Lymphedema: Physiological Considerations

Author Outcomes

Muluk, et al (2013)European J of VascEndovasc Surg

Legs:  Significant Limb volume; significantly improved patient‐reported outcomes

Fife, et al (2012)Supportive Care in Cancer

BCRL: 29%Limb volume vs 16% limb volume with standard pump use

Adams, et al (2010)Biomedical Optics Express

Increased propulsion rates in healthy and BCRL patients; improved lymphatic function systemically

Author Outcomes

Muluk, et al (2013)European J of VascEndovasc Surg

Legs:  Significant Limb volume; significantly improved patient‐reported outcomes

Fife, et al (2012)Supportive Care in Cancer

BCRL: 29%Limb volume vs 16% limb volume with standard pump use

Adams, et al (2010)Biomedical Optics Express

Increased propulsion rates in healthy and BCRL patients; improved lymphatic function systemically

Research Study Outcomes

Page 29: IPC Use in Lymphedema: Physiological Considerations

Author Outcomes

Muluk, et al (2013)European J of VascEndovasc Surg

Legs:  Significant Limb volume; significantly improved patient‐reported outcomes

Fife, et al (2012)Supportive Care in Cancer

BCRL: 29%Limb volume vs 16% limb volume with standard pump use

Adams, et al (2010)Biomedical Optics Express

Increased propulsion rates in healthy and BCRL patients; improved lymphatic function systemically

Ridner, et al (2010)Lymphatic Research & Biology

BCRL of the trunk: Significant improvement in truncal symptoms and sleep

Author Outcomes

Muluk, et al (2013)European J of VascEndovasc Surg

Legs:  Significant Limb volume; significantly improved patient‐reported outcomes

Fife, et al (2012)Supportive Care in Cancer

BCRL: 29%Limb volume vs 16% limb volume with standard pump use

Adams, et al (2010)Biomedical Optics Express

Increased propulsion rates in healthy and BCRL patients; improved lymphatic function systemically

Ridner, et al (2010)Lymphatic Research & Biology

BCRL of the trunk: Significant improvement in truncal symptoms and sleep

Research Study Outcomes

Page 30: IPC Use in Lymphedema: Physiological Considerations

Author Outcomes

Muluk, et al (2013)European J of VascEndovasc Surg

Legs:  Significant Limb volume; significantly improved patient‐reported outcomes

Fife, et al (2012)Supportive Care in Cancer

BCRL: 29%Limb volume vs 16% limb volume with standard pump use

Adams, et al (2010)Biomedical Optics Express

Increased propulsion rates in healthy and BCRL patients; improved lymphatic function systemically

Ridner, et al (2010)Lymphatic Research & Biology

BCRL of the trunk: Significant improvement in truncal symptoms and sleep

Wilburn, et al (2006)BMC Cancer

BCRL: Significant Limb volume but no improvement with self‐massage

Author Outcomes

Muluk, et al (2013)European J of VascEndovasc Surg

Legs:  Significant Limb volume; significantly improved patient‐reported outcomes

Fife, et al (2012)Supportive Care in Cancer

BCRL: 29%Limb volume vs 16% limb volume with standard pump use

Adams, et al (2010)Biomedical Optics Express

Increased propulsion rates in healthy and BCRL patients; improved lymphatic function systemically

Ridner, et al (2010)Lymphatic Research & Biology

BCRL of the trunk: Significant improvement in truncal symptoms and sleep

Wilburn, et al (2006)BMC Cancer

BCRL: Significant Limb volume but no improvement with self‐massage

Research Study Outcomes

Page 31: IPC Use in Lymphedema: Physiological Considerations